Biovian Oy. (9/6/22). "Press Release: Biovian Appoints Its First US-based Business Development Manager".

	Organisation	Biovian Oy
	Organisation 2	Cellectis Inc.
	Group	Cellectis (Group)
	Product	contract manufacturing (biologicals)
	Product 2	viral vector production technology
	Person	Allen, Allison (Biovian 202209– Business Development Manager based in US before Cellectis + Alcami + Thermo Fisher)
	Person 2	Nieminen, Antti (Biovian 202303 CEO + Co-Founder)

Biovian welcomes Allison Allen to drive new market entry and client acquisition in the worlds largest viral vector market

Biovian, a Nordic Bio-CDMO committed to providing premium One-Stop-Shop GMP services to biotech companies, is delighted to announce that Allison Allen based in North Carolina has been appointed Business Development Manager. Ms. Allen will be a strong addition to the business and marketing team and will be giving her contribution to the growth acceleration of the company. In her position Ms. Allen will be responsible for identifying new business opportunities within predominately the North American market with a focus on the US.

“We are very pleased that Allison Allen will assume the role of Business Development Manager at Biovian” Antti Nieminen, CEO of Biovian, states. “Her background and understanding of the North American Viral Vector market make Ms. Allen an excellent fit for this important role. We look forward to working with her as we continue to implement Biovian’s viral vector growth objective.”

Prior to joining Biovian Allison Allen worked as Director of Project Management for Cellectis with the objective of leading the technical transfer of company-owned products to the new manufacturing facility in Raleigh, NC. Allison has a wealth of experience in the CDMO business from his previous roles. At Alcami she led the project management and also served on the site leadership team. She has also worked at Thermo Fisher, Emergent, and Paragon.

About Biovian

Biovian is a CDMO that provides premium services to biotech companies developing innovative gene therapies or biopharmaceuticals. Biovian offers its clients a One-Stop-Shop GMP CDMO service, with modularity available from gene to finished vial. Biovian is especially focusing on Viral Vector production, microbial production of recombinant proteins, and GMP plasmid DNA. Guided by its Nordic ethos Biovian has established a reputation for delivering high-quality work on time and within budget to a global client base. Additional information is available at https://biovian.com/

Communication Contact:

Dr. Magnus Gustafsson, CBO
+46 70 723 1010/ [email protected]

Record changed: 2024-01-06